After diagnosis and treatment of prostate cancer, men who predominantly consumed plant-based diets had disease progression only half as often as men who did not follow this diet, according to a US ...

The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...

Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.

In some cases, prostate cancer resists all known therapies and turns extremely deadly. Now, a discovery at Cold Spring Harbor Laboratory (CSHL) points to a potential solution. Researchers led by CSHL ...

A recent study published in the Journal of Cancer Research and Clinical Oncology explored genetic predictors of prostate cancer progression to help identify its clinical outcomes. Conducted by ...

Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic body radiotherapy (SBRT) went more than twice as long without their disease ...

New therapies being developed are moving into earlier lines of therapy, with the idea that most patients with early-stage prostate cancer will progress and need additional therapy later. With new ...

Men with prostate cancer who ate more servings of fruits, vegetables, and grains had an almost 50 percent lower risk of the cancer spreading compared with those who ate fewer plant-based foods. Eating ...

The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...

Researchers have identified chromosomal instability in circulating tumour cells as a prognostic and predictive biomarker in ...